| Dr Ghassan Mohamad Hammoud, MD, MBBCH, MPH | |
|
101 S Fairview Rd, Columbia, MO 65203-7637 | |
| (573) 884-7600 | |
| (573) 884-8200 |
| Full Name | Dr Ghassan Mohamad Hammoud |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 30 Years |
| Location | 101 S Fairview Rd, Columbia, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205806882 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Missouri Health Care | Columbia, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Curators Of The University Of Missouri | 4486759560 | 959 |
News Archive
A two-year, multi-center clinical study with 167 patients with class III-IV refractory angina randomized to low and high dose CD34+ cells or placebo has revealed that patients who received either a high or low dose of CD34 - a member of a family of proteins that have an impact on vascular-associated tissue - cells had a significant reduction in angina frequency over patients who received placebo.
Onset Medical Corporation announced today that the United States Patent Office has notified the Company a new patent has issued entitled "Expandable Transluminal Sheath." This new patent provides 24 claims surrounding Onset's fundamental Controlled Deployment Technology platform.
BASF and the University of North Carolina at Chapel Hill today announced the signing of a Master Research Agreement.
A blood test on hospital admission showing the presence or absence of SARS-CoV-2 can identify patients at a high risk of severe COVID-19.
› Verified 7 days ago
| Entity Name | The Curators Of The University Of Missouri |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235126921 PECOS PAC ID: 4486759560 Enrollment ID: O20070418000290 |
News Archive
A two-year, multi-center clinical study with 167 patients with class III-IV refractory angina randomized to low and high dose CD34+ cells or placebo has revealed that patients who received either a high or low dose of CD34 - a member of a family of proteins that have an impact on vascular-associated tissue - cells had a significant reduction in angina frequency over patients who received placebo.
Onset Medical Corporation announced today that the United States Patent Office has notified the Company a new patent has issued entitled "Expandable Transluminal Sheath." This new patent provides 24 claims surrounding Onset's fundamental Controlled Deployment Technology platform.
BASF and the University of North Carolina at Chapel Hill today announced the signing of a Master Research Agreement.
A blood test on hospital admission showing the presence or absence of SARS-CoV-2 can identify patients at a high risk of severe COVID-19.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ghassan Mohamad Hammoud, MD, MBBCH, MPH Po Box 843966, Kansas City, MO 64184-3966 Ph: (573) 884-3300 | Dr Ghassan Mohamad Hammoud, MD, MBBCH, MPH 101 S Fairview Rd, Columbia, MO 65203-7637 Ph: (573) 884-7600 |
News Archive
A two-year, multi-center clinical study with 167 patients with class III-IV refractory angina randomized to low and high dose CD34+ cells or placebo has revealed that patients who received either a high or low dose of CD34 - a member of a family of proteins that have an impact on vascular-associated tissue - cells had a significant reduction in angina frequency over patients who received placebo.
Onset Medical Corporation announced today that the United States Patent Office has notified the Company a new patent has issued entitled "Expandable Transluminal Sheath." This new patent provides 24 claims surrounding Onset's fundamental Controlled Deployment Technology platform.
BASF and the University of North Carolina at Chapel Hill today announced the signing of a Master Research Agreement.
A blood test on hospital admission showing the presence or absence of SARS-CoV-2 can identify patients at a high risk of severe COVID-19.
› Verified 7 days ago
Dr. Rahul Jain, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-884-2296 Fax: 573-884-7743 | |
Gregory Gaskey, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-884-9066 Fax: 573-884-3037 | |
Christos N Papageorgiou, M.D., PHD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: One Hospital Drive, Columbia, MO 65212 Phone: 573-882-2100 Fax: 573-884-7822 | |
Jack Bragg, DO Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 101 S Fairview Road, Columbia, MO 65201 Phone: 573-884-7600 Fax: 573-884-8200 | |
Michelle Middleton Woodson, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 800 Hospital Dr, Columbia, MO 65201 Phone: 573-814-6000 Fax: 573-814-6584 | |
Dr. Sameer Bellapravalu, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Drive Room 313, Psychiatry Dept Dc067.00, Columbia, MO 65212 Phone: 573-884-6136 Fax: 573-884-1070 | |
Trenton Bickel, Gastroenterology Medicare: Medicare Enrolled Practice Location: 1 Hospital Dr # Dc043.00, Columbia, MO 65212 Phone: 573-882-7272 |